Estimated Medicare Part B Savings From Inflationary Rebates

被引：3

作者：

Egilman, Alexander C. C. ^{[1
]}

Kesselheim, Aaron S. S. ^{[1
]}

Rome, Benjamin N. N. ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 01期

关键词：

D O I：

10.1001/jama.2022.20189

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This study uses annual Medicare Part B spending data to examine the potential savings from the drug pricing reforms in the Inflation Reduction Act of 2022.

引用

页码：89 / 92

页数：4

共 6 条

[1]

[Anonymous], 2021, INFLATION REDUCTION

[2]

Centers for Medicare & Medicaid Services, MED B

[3]

Centers for Medicare & Medicaid Services, ASP DRUG PRIC FIL

[4]

Cubanski J., PRICES INCREASED FAS

[5]

Freed M., 2022, Medicare Advantage in 2022: Enrollment Update and Key Trends

[6] Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018 [J].

Hernandez, Inmaculada ;

San-Juan-Rodriguez, Alvaro ;

Good, Chester B. ;

Gellad, Walid F. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (09) :854-862

← 1 →